Among pregnant women at high risk of early preeclampsia, testing for abnormal cardiac function as early as 14 weeks of gestation could help predict risk of adverse outcomes, according to a study presented at the International Society of Ultrasound in Obstetrics and Gynecology world congress. Echocardiograms could be used as a well-tolerated screening exam, researcher Kate Russo said.

Related Summaries